StockData
PDS Biotechnology Corp logo

PDS Biotechnology Corp (PDSB) stock

PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.78−0.11 (-12.27%)

Close on Nov 18, 2026Market cap $43.89MP/E –Yield –

PDS Biotechnology revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for PDS Biotechnology

PDS Biotechnology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More PDS Biotechnology figures

See a number that looks wrong?